Cell-therapy due diligence for patients in the United Kingdom
A country-specific starting point for checking product authorisation, trial oversight and cross-border follow-up. This page does not rank providers or recommend medical travel.
What the regulator can confirm
The MHRA is the UK competent authority for advanced therapy medicinal products, including somatic-cell therapies and tissue-engineered products. Its guidance distinguishes marketing authorisation, authorised clinical trials, hospital exemption and the specials route; these routes are not interchangeable. A manufacturer licence or tissue licence alone does not establish that a specific treatment is authorised for a specific condition.
Before receiving treatment in the UK or abroad, request the exact product classification, authorisation or trial reference, responsible manufacturer and treating entity. Verify those details with the MHRA or the relevant foreign authority and arrange independent clinical review, insurance and a written follow-up plan.
Evidence to request before treatment
| Question | Document or identifier | Why it matters |
|---|---|---|
| What exactly is administered? | Product name, cell source, processing, dose and route | Evidence and legal status are product- and indication-specific. |
| What is the legal route? | Marketing authorisation, authorised trial number, or named exemption and authority | A clinic licence or registry listing does not by itself authorise a product. |
| Who manufactures it? | Legal manufacturer, site and authorisation scope | General references to GMP are not a substitute for a current, applicable record. |
| How are harms managed? | Consent form, adverse-event plan, insurance and emergency contact | Experimental status does not remove the duty to disclose and manage risk. |
| What happens after travel? | Written follow-up plan and named clinician | Cross-border care can complicate continuity and reporting. |
Conditions compared
Educational regulatory orientation, reviewed in 2026. Verify current records directly with the authority and seek independent medical advice.